Juha Rinne
jurin@utu.fi +358 50 441 2400 |
- Associations of Prediabetes, Diabetes and Glucose‐Related Markers With Cognition and Neuroimaging in a 2‐Year Multidomain Lifestyle Randomised Controlled Trial (2025)
- Diabetes/Metabolism Research and Reviews
- Cognitive decline over 7 years in aging patients with childhood-onset epilepsy: A population-based prospective follow-up study (2025)
- Journal of the International Neuropsychological Society
- Depressive Symptoms and Amyloid Pathology (2025)
- JAMA Psychiatry
- Enhancing dementia prediction: A 19-year validation of the CAIDE risk score with insulin resistance and APOE ε4 integration in a population-based cohort (2025)
- The Journal of Prevention of Alzheimer's Disease
- Impaired Gait, Postural Instability, and Rigidity in Relation to CB1 Receptor Availability in Parkinson's Disease (2025)
- Movement Disorders
- Kognitiiviset oireet Parkinsonin taudissa (2025) Parkinson-potilaan hoidon hyvät käytännöt Ellfolk, Ulla; Karrasch, Mira; Rinne, Juha
- Metabolic dysfunction-associated steatotic liver disease as a predictor of cognitive performance: An 11-year population-based follow-up study (2025)
- Digestive and Liver Disease
- Monoallelic TYROBP deletion is a novel risk factor for Alzheimer’s disease (2025)
- Molecular Neurodegeneration
- Neuroinflammation in Parkinson’s disease : A study with [11C]PBR28 PET and cerebrospinal fluid markers (2025)
- Parkinsonism and Related Disorders
- Parkinson-potilaan kognitiivisten oireiden arviointi (2025) Parkinson-potilaan hoidon hyvät käytännöt Ellfolk, Ulla; Karrasch, Mira; Rinne, Juha
- Parkinson-potilaan kognitiivisten oireiden hoito (2025) Parkinson-potilaan hoidon hyvät käytännöt Ellfolk, Ulla; Karrasch, Mira; Rinne, Juha
- Progression of Amyloid Accumulation in Late Adulthood Among People With Childhood-Onset Epilepsy (2025)
- Neurology
- Synaptic Density in Multiple Sclerosis (2025)
- Neurology, Neuroimmunology and Neuroinflammation
- The protective PLCγ2-P522R variant mitigates Alzheimer’s disease-associated pathologies by enhancing beneficial microglial functions (2025)
- Journal of Neuroinflammation
- Alterations in type 2 dopamine receptors across neuropsychiatric conditions: A large-scale PET cohort (2024)
- NeuroImage: Clinical
- Alzheimerin taudin lääkehoito (2024) Lääketieteellinen farmakologia ja toksikologia Rinne, Juha; Scheinin, Mika
- Alzheimerin tauti sairautena (2024) Lääketieteellinen farmakologia ja toksikologia Rinne, Juha; Scheinin, Mika
- Alzheimer's disease genetic risk score and neuroimaging in the FINGER lifestyle trial (2024)
- Alzheimer's and Dementia
- Author Correction: Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer’s disease: a phase 1b, randomized, placebo-controlled trial (Nature Medicine, (2023), 29, 6, (1437-1447), 10.1038/s41591-023-02326-3) (2024)
- Nature Medicine
- Blood biomarkers of neurodegeneration associate differently with amyloid deposition, medial temporal atrophy, and cerebrovascular changes in APOE ε4-enriched cognitively unimpaired elderly (2024)
- Alzheimer's Research and Therapy